Imperial College London

ProfessorGaryFrost

Faculty of MedicineDepartment of Metabolism, Digestion and Reproduction

Chair in Nutrition & Dietetics
 
 
 
//

Contact

 

+44 (0)20 7594 0959g.frost Website

 
 
//

Location

 

Commonwealth BiuldingHammersmith HospitalHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Bottin:2016:10.1017/S0007114516001872,
author = {Bottin, JH and Swann, JR and Cropp, E and Chambers, ES and Ford, HE and Ghatei, MA and Frost, GS},
doi = {10.1017/S0007114516001872},
journal = {British Journal of Nutrition},
pages = {360--374},
title = {Mycoprotein reduces energy intake and postprandial insulin release without altering glucagon-like peptide-1 and peptide tyrosine-tyrosine concentrations in healthy overweight and obese adults: a randomised-controlled trial},
url = {http://dx.doi.org/10.1017/S0007114516001872},
volume = {116},
year = {2016}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Dietary mycoprotein decreases energy intake in lean individuals. The effects in overweight individuals are unclear, and the mechanisms remain to be elucidated. This study aimed to investigate the effect of mycoprotein on energy intake, appetite regulation, and the metabolic phenotype in overweight and obese volunteers. In two randomised-controlled trials, fifty-five volunteers (age: 31 (95 % CI 27, 35) years), BMI: 28·0 (95 % CI 27·3, 28·7) kg/m2) consumed a test meal containing low (44 g), medium (88 g) or high (132 g) mycoprotein or isoenergetic chicken meals. Visual analogue scales and blood samples were collected to measure appetite, glucose, insulin, peptide tyrosine-tyrosine (PYY) and glucagon-like peptide-1 (GLP-1). Ad libitum energy intake was assessed after 3 h in part A (n 36). Gastric emptying by the paracetamol method, resting energy expenditure and substrate oxidation were recorded in part B (n 14). Metabonomics was used to compare plasma and urine samples in response to the test meals. Mycoprotein reduced energy intake by 10 % (280 kJ (67 kcal)) compared with chicken at the high content (P=0·009). All mycoprotein meals reduced insulin concentrations compared with chicken (incremental AUClow (IAUClow): -8 %, IAUCmedium: -12 %, IAUChigh: -21 %, P=0·004). There was no significant difference in glucose, PYY, GLP-1, gastric emptying rate and energy expenditure. Following chicken intake, paracetamol-glucuronide was positively associated with fullness. After mycoprotein, creatinine and the deamination product of isoleucine, α-keto-β-methyl-N-valerate, were inversely related to fullness, whereas the ketone body, β-hydroxybutyrate, was positively associated. In conclusion, mycoprotein reduces energy intake and insulin release in overweight volunteers. The mechanism does not involve changes in PYY and GLP-1. The metabonomics analysis may bring new understanding to the appetite regulatory properties of food.
AU - Bottin,JH
AU - Swann,JR
AU - Cropp,E
AU - Chambers,ES
AU - Ford,HE
AU - Ghatei,MA
AU - Frost,GS
DO - 10.1017/S0007114516001872
EP - 374
PY - 2016///
SN - 1475-2662
SP - 360
TI - Mycoprotein reduces energy intake and postprandial insulin release without altering glucagon-like peptide-1 and peptide tyrosine-tyrosine concentrations in healthy overweight and obese adults: a randomised-controlled trial
T2 - British Journal of Nutrition
UR - http://dx.doi.org/10.1017/S0007114516001872
UR - http://hdl.handle.net/10044/1/34226
VL - 116
ER -